About the organization
Basic details : Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products.
At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Mission : Our mission is to discover new ways to improve and extend people's lives.
Vision : Our vision is to be a trusted leader in changing the practice of medicine.
Global Head of Patient Advocacy at Novartis
Head Patient Communications and Advocacy, Sandoz International
Senior Director Group Patient Advocacy & Communications
Intern Oncology GMA Patient Eng Projects
Driving patient focused initiatives within our patient access & drug development strategies
Patient Affairs Research ＆ Policy Director
East Hanover, United States
Global Patient Engagement Manager Pharma
Andreina De Leon Carmenatis
Patient Advocacy Manager
Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies (Leaflet)
20 Mar 2019
The Economist Index of Cancer Preparedness
03 Apr 2019
18 Oct 2019 Publication